-
Argus: Anthrax Vaccine Maker Emergent BioSolutions Poised For Earnings Growth
Wednesday, June 13, 2018 - 10:51am | 365Read More...Emergent Biosolutions Inc (NYSE: EBS), a maker of vaccines and products for infectious diseases as well as chemical, biological or nuclear attacks, picked up a sell-side bull Wednesday. The Analyst Argus analyst Mike Jaffe initiated coverage of Emergent BioSolutions with a Buy and $62...
-
Argus: VF Corp. Shares Merit Higher Multiple, Hold 26% Upside Potential
Monday, May 21, 2018 - 9:04am | 341Read More...Despite the generally cautious outlook on retailers, one Argus analyst is upbeat about apparel and footwear retailer VF Corp (NYSE: VFC). The Analyst Analyst Mike Jaffe initiated coverage of VF Corp. shares with a Buy rating and $101 price target, suggesting roughly 26-percent upside....
-
Harris Will Benefit From A 'Substantial Increase' In Military Spending, Argus Says
Wednesday, April 4, 2018 - 1:19pm | 304Read More...President Donald Trump's commitment to support the U.S. military bodes well for Harris Corporation (NYSE: HRS), according to Argus. The Analyst Argus' Mike Jaffe initiated coverage of Harris' stock with a Buy rating and $196 price target. The Thesis Harris, a provider of...
-
Argus: Albemarle Has 30% Upside On Strong Lithium Demand
Friday, February 23, 2018 - 10:36am | 376Read More...Albemarle Corporation (NYSE: ALB) is likely to benefit from a strong lithium outlook, according to Argus. The Analyst Analyst Mike Jaffe initiated coverage of shares of Albemarle with a Buy rating and a $148 price target, suggesting roughly 30 percent upside from current levels. The...
